Wird geladen...
Panels and models for accurate prediction of tumor mutation burden in tumor samples
Immune checkpoint blockade (ICB) is becoming standard-of-care in many types of human malignancies, but patient selection is still imperfect. Tumor mutation burden (TMB) is being evaluated as a biomarker for ICB in clinical trials, but most of the sequencing panels used to estimate it are inadequatel...
Gespeichert in:
| Veröffentlicht in: | NPJ Precis Oncol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Nature Publishing Group UK
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8044185/ https://ncbi.nlm.nih.gov/pubmed/33850256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-021-00169-0 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|